Literature DB >> 6771215

Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.

M N Gwynn, G N Rolinson.   

Abstract

In broth cultures of Pseudomonas aeruginosa, containing carbenicillin or azlocillin, regrowth occurred after a period of bactericidal action, to reach visible proportions overnight. Regrowth in the presence of relatively high concentrations of carbenicillin or azlocillin could not be accounted for on the basis of growth of resistant variants nor as a result of drug inactivation. On the other hand, resistant variants could be selected from the regrowth which occurred at concentrations of carbenicillin or azlocillin only slight in excess of the minimum inhibitory concentrations (MIC). Antibiotic resistant variants could also be isolated from individual colonies growing on agar plates containing carbenicillin, ticarcillin, azlocillin or piperaccillin at concentrations above the MIC for the majority of the population. Two types of resistant variant were isolated. The first showed a 2-5 fold increase in resistance to carbenicillin, ticarcillin, azlocillin and piperacillin while Beta-lactamase production in these variants appeared to be unchanged. The second type of resistant variant showed unchanged sensitivity to carbenicillin and ticarcillin, or only a slight increase in resistance, whereas resistance to azlocillin and piperacillin was increased as much as 40-fold or more. These variants showed increased constitutive Beta-lactamase production and may be derepressed mutants of the parent culture. Variants of this type were readily selected by culture in the presence of azlocillin or piperacillin but only infrequently as a result of culture in the presence of carbenicillin or ticarcillin. The existence in cultures of P. aeruginosa of variants showing elevated Beta-lactamase production may account at least in part for the effect of inoculum size on the activity of azlocillin and piperacillin against P. aeruginosa and the marked discrepancy between MIC and minimum bactericidal concentration (MBC) which is characteristic of the ureido penicillins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771215     DOI: 10.1007/bf01639151

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  19 in total

1.  Piperacillin: in vitro evaluation.

Authors:  G P Bodey; B Le Blanc
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

2.  Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea.

Authors:  W Brumfitt; A Percival; D A Leigh
Journal:  Lancet       Date:  1967-06-17       Impact factor: 79.321

3.  R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.

Authors:  R B Sykes; M H Richmond
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

4.  Resistance of Pseudomonas aeruginosa to carbenicillin.

Authors:  S M Bell; D D Smith
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

5.  Mutant of Pseudomonas aeruginosa 18S that synthesizes type Id beta-lactamase constitutively.

Authors:  F Flett; N A Curtis; M H Richmond
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

6.  Azlocillin: in vitro studies of a new semisynthetic penicillin.

Authors:  D Stewart; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

7.  Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.

Authors:  M J Basker; R A Edmondson; R Sutherland
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Laboratory and clinical evaluation of carbenicillin (carboxybenzyl penicillin).

Authors:  F Silverblatt; M Turck
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1968

9.  Azlocillin and mezlocillin: new ureido penicillins.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

10.  Carbenicillin resistance in Pseudomonas aeruginosa from clinical material.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1969-07-19
View more
  5 in total

1.  Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.

Authors:  I Odenholt; B Isaksson; L Nilsson; O Cars
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-02       Impact factor: 3.267

2.  Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.

Authors:  P Casey; M Glauser
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

3.  Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics.

Authors:  W Cullman; K H Büscher; W Dick
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

4.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

5.  Inoculum effect of beta-lactam antibiotics on Enterobacteriaceae.

Authors:  R H Eng; C Cherubin; S M Smith; F Buccini
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.